المؤلفون: Karlan BY, Oza AM, Richardson GE, Provencher DM, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippitt CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Nguyen H, Stepan DE, Weinreich DM, Tassoudji M, Sun YN, Vergote IB

المصدر: Journal of Clinical Oncology; 2/1/2012, Vol. 30 Issue 4, p362-371, 10p

المؤلفون: Reed BG, Lowery WJ, Keyser EA, Kost ER, Sundborg MJ, Winter WE 3rd, Landt C, Leath CA 3rd

المصدر: American Journal of Obstetrics & Gynecology; Oct2011, Vol. 205 Issue 4, p356.e1-5, 1p

المؤلفون: Lowery WJ, Song WS, Leath CA 3rd, Lowery, William J, Song, Won S, Leath, Charles A 3rd

المصدر: American Journal of Obstetrics & Gynecology; Aug2009, Vol. 201 Issue 2, p223.e1-2, 1p

المؤلفون: Ketch PW; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Zaharias RS; Division of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Aug; Vol. 25 (12), pp. 1591-1603. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/therapy , Chemoradiotherapy*/methods , Neoplasm Recurrence, Local*/drug therapy , Standard of Care*, Humans ; Female ; Progression-Free Survival ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy/methods ; Neoplasm Staging ; Antineoplastic Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Pitiyarachchi O; School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia., Ansell PJ; AbbVie Inc, North Chicago, IL, USA., Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinh MH; AbbVie Inc, North Chicago, IL, USA., Holman L; Stephenson Cancer Center, University of Oklahoma, OK, USA., Leath CA 3rd; The University of Alabama at Birmingham-Deep South Research Consortium, O'Neal Comprehensive Cancer Center, University of Alabama Hospital, Birmingham, AL, USA., Werner T; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., DiSilvestro P; Women and Infants Hospital, Providence, RI, USA., Morgan M; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA., Tew W; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee C; Texas Oncology - The Woodlands - USO, TX, USA., Cunningham M; Gynecologic Oncology, SUNY Upstate Medical University, Syracuse, NY, USA., Newton M; University of North Carolina School of Medicine, Chapel Hill, NC, USA., Edraki B; John Muir Medical Center, Walnut Creek, CA, USA., Lim P; Center of Hope, Reno, NV, USA., Barlin J; Division of Gynecologic Oncology, Albany Medical College, Albany, NY, USA., Spirtos NM; Women's Cancer Center, Las Vegas, NV, USA., Tewari KS; Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of California, Irvine, CA, USA., Edelson M; Jefferson Abington Hospital, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Reid T; Kettering Health University of Cincinnati, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and Advanced Pelvic Surgery, Cincinnati, OH, USA., Carlson J; Mercy Health, St. Louis, MO, USA., Friedlander M; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia; Department of Medical Oncology, The Prince of Wales and Royal Hospital for Women, Randwick, NSW, Australia. Electronic address: m.friedlander@unsw.edu.au.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 221-226. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , BRCA1 Protein*/genetics, Humans ; Female ; Aged ; Middle Aged ; BRCA2 Protein/genetics ; Aged, 80 and over ; Age Factors ; Adult ; Homologous Recombination ; Neoplasm Staging ; Neoplasm Grading ; Genetic Testing/methods

المؤلفون: Castellano T; Department of Gynecologic Oncology, Louisiana State University, New Orleans, Louisiana, United States of America., ElHabr AK; Value Analytics Labs, Boston, Massachusetts, United States of America., Washington C; Department of Obstetrics and Gynecology, Stephenson Cancer Center, Oklahoma City, Oklahoma, United States of America., Ting J; Pfizer Inc., Bothell, Washington, United States of America., Zhang YJ; Pfizer Inc., Bothell, Washington, United States of America., Musa F; Swedish Cancer Institute, Seattle, Washington, United States of America., Berksoy E; Value Analytics Labs, Boston, Massachusetts, United States of America., Moore K; Pfizer Inc., Bothell, Washington, United States of America., Randall L; Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, Virginia, United States of America., Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical University, Boston, Massachusetts, United States of America., Ayer T; Department of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America.; Department of Medicine, Emory University, Atlanta, Georgia, United States of America., Leath CA 3rd; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

المصدر: PloS one [PLoS One] 2024 Jul 18; Vol. 19 (7), pp. e0307282. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/therapy , Uterine Cervical Neoplasms*/epidemiology , Uterine Cervical Neoplasms*/diagnosis , Socioeconomic Factors*, Humans ; Female ; Middle Aged ; United States/epidemiology ; Adult ; Aged ; Healthcare Disparities/statistics & numerical data ; Cost of Illness ; Early Detection of Cancer/statistics & numerical data ; Health Status Disparities ; Risk Factors

المؤلفون: Horowitz NS; Brigham and Women's Hospital/Dana-Farber Cancer Institute., Deng W; NRG Oncology/Gynecologic Oncology Group Statistics & Data Center, Buffalo, NY., Peterson I; Mayo Clinic, Rochester, MN., Mannel RS; University of Oklahoma Health Sciences Center, Oklahoma City, OK., Thompson S; University of Oklahoma Health Sciences Center, Oklahoma City, OK., Lokich E; Women's and Infants Hospital, Providence, RI., Myers T; Bay State Health, Springfield, MA., Hanjani P; Abington Health, Abington, PA., O'Malley DM; The James CCC & The Ohio State University Wexner Medical Center, Columbus, OH., Chung KY; Prisma Health Cancer Institute, Greenville, SC., Miller DS; University of Texas Southwestern Medical Center, Dallas, TX., Ueland FR; University of Kentucky College of Medicine, Lexington, KY., Dizon DS; Lifespan, Providence, RI., Miller A; NRG Oncology/Gynecologic Oncology Group Statistics & Data Center, Buffalo, NY., Mayadev JS; University of California San Diego School of Medicine, La Jolla, CA., Leath CA 3rd; O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham; Birmingham, AL., Monk BJ; GOG Partners at The GOG Foundation Inc, Phoenix, AZ.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1914-1921. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Vulvar Neoplasms*/pathology , Vulvar Neoplasms*/radiotherapy , Vulvar Neoplasms*/drug therapy , Vulvar Neoplasms*/mortality , Vulvar Neoplasms*/therapy , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Cisplatin*/administration & dosage , Cisplatin*/therapeutic use , Gemcitabine* , Carcinoma, Squamous Cell*/pathology , Carcinoma, Squamous Cell*/therapy , Carcinoma, Squamous Cell*/radiotherapy , Carcinoma, Squamous Cell*/mortality , Carcinoma, Squamous Cell*/drug therapy , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/administration & dosage , Deoxycytidine*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Middle Aged ; Adult ; Chemoradiotherapy/methods ; Progression-Free Survival

المؤلفون: Winkler SS; Division of Gynecologic Oncology, Department of Gynecologic Surgery and Obstetrics, Brooke Army Medical Center, San Antonio, TX, USA., Tian C; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA., Casablanca Y; Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Bateman NW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA., Jokajtys S; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Kucera CW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Tarney CM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Chan JK; Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health, San Francisco, CA, USA., Richardson MT; Department of Obstetrics and Gynecology, University of California, Los Angeles School of Medicine, Los Angeles, CA. USA., Kapp DS; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA., Liao CI; Division of Obstetrics and Gynecology, Pingtung Veterans General Hospital, Pingtung, Taiwan., Hamilton CA; Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Reddy M; California Pacific Medical Center, San Francisco, CA, USA., Cote ML; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA., O'Connor TD; Institute for Genome Sciences, Department of Medicine, Program in Personalized and Genomic Medicine, University of Maryland School of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Jones NL; Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA., Rocconi RP; Division of Gynecologic Oncology, Cancer Center & Research Institute, The University of Mississippi Medical Center, Jackson, MS, USA., Powell MA; Division of Gynecologic Oncology, Siteman Cancer Center, Washington University, St Louis, MO, USA., Farley J; Division of Gynecologic Oncology, Center for Women's Health, Cancer Institute, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA., Shriver CD; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Conrads TP; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA., Phippen NT; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Maxwell GL; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA., Darcy KM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA. Electronic address: darcyk@whirc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 May; Vol. 184, pp. 31-42. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms*/ethnology , Endometrial Neoplasms*/pathology, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Adenocarcinoma, Clear Cell/pathology ; Adenocarcinoma, Clear Cell/ethnology ; Adenocarcinoma, Clear Cell/epidemiology ; American Indian or Alaska Native ; Asian American Native Hawaiian and Pacific Islander ; Black or African American/statistics & numerical data ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/ethnology ; Carcinosarcoma/pathology ; Carcinosarcoma/ethnology ; Cystadenocarcinoma, Serous/pathology ; Cystadenocarcinoma, Serous/ethnology ; Ethnicity/statistics & numerical data ; Health Status Disparities ; Hispanic or Latino/statistics & numerical data ; Native Hawaiian or Other Pacific Islander/statistics & numerical data ; United States/epidemiology ; White People/statistics & numerical data

المؤلفون: Kucera CW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Chappell NP; George Washington Medical Faculty Associates, George Washington Cancer Center, Washington, DC, USA., Tian C; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Richardson MT; Department of Obstetrics and Gynecology, University of California, Los Angeles School of Medicine, Los Angeles, CA. USA., Tarney CM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Hamilton CA; Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA., Chan JK; Palo Alto Medical Foundation / California Pacific Medical Center /Sutter Health, San Francisco, CA, USA., Kapp DS; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Casablanca Y; Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Rojas C; Division of Gynecologic Oncology, Naval Medical Center Portsmouth, Portsmouth, VA, USA., Sitler CA; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Wenzel L; School of Medicine, University of California Irvine, Irvine, CA, USA., Klopp A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jones NL; Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA., Rocconi RP; Division of Gynecologic Oncology, Cancer Center & Research Institute, the University of Mississippi Medical Center, Jackson, MS, USA., Farley JH; Division of Gynecologic Oncology, Center for Women's Health, Cancer Institute, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA., O'Connor TD; Institute for Genome Sciences, Department of Medicine and Program in Personalized and Genomic Medicine, and Program in Health Equity and Population Health, University of Maryland School of Medicine, Baltimore, MD, USA; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Shriver CD; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Bateman NW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Conrads TP; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Women's Health Integrated Research Center, Inova Women's Service Line, Inova Health System, Falls Church, VA, USA., Phippen NT; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Maxwell GL; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Women's Health Integrated Research Center, Inova Women's Service Line, Inova Health System, Falls Church, VA, USA., Darcy KM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. Electronic address: darcyk@whirc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 May; Vol. 184, pp. 224-235. Date of Electronic Publication: 2024 Feb 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Black or African American*/statistics & numerical data , Carcinoma, Squamous Cell*/pathology , Carcinoma, Squamous Cell*/ethnology , Carcinoma, Squamous Cell*/mortality , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/ethnology , Uterine Cervical Neoplasms*/mortality , White People*/statistics & numerical data, Adult ; Aged ; Female ; Humans ; Middle Aged ; Adenocarcinoma/pathology ; Adenocarcinoma/ethnology ; Adenocarcinoma/mortality ; Health Status Disparities ; Healthcare Disparities/ethnology ; Healthcare Disparities/statistics & numerical data ; Neoplasm Staging ; Proportional Hazards Models ; Socioeconomic Factors ; United States/epidemiology

المؤلفون: Kopelman ZA; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Tian C; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA., Tumas J; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Phippen NT; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Tarney CM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Hope ER; Division of Gynecologic Oncology, Department of Gynecologic Surgery and Obstetrics, Brooke Army Medical Center, San Antonio, TX, USA., Winkler SS; Division of Gynecologic Oncology, Department of Gynecologic Surgery and Obstetrics, Brooke Army Medical Center, San Antonio, TX, USA., Jokajtys S; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Kucera CW; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA., Chan JK; Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health, San Francisco, CA, USA., Richardson MT; Department of Obstetrics and Gynecology, University of California, Los Angeles School of Medicine, Los Angeles, CA, USA., Kapp DS; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA., Hamilton CA; Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Jones NL; Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA., Rocconi RP; Division of Gynecologic Oncology, Cancer Center & Research Institute, the University of Mississippi Medical Center, Jackson, MS, USA., Farley JH; Division of Gynecologic Oncology, Center for Women's Health, Cancer Institute, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA., Secord AA; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA., Cosgrove CM; Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, USA., Powell MA; Division of Gynecologic Oncology, Siteman Cancer Center, Washington University, St Louis, MO, USA., Klopp A; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Walker JL; Gynecologic Oncology Division, Stephenson Cancer Center, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Fleming GF; Department of Medicine, University of Chicago, Chicago, IL, USA., Bateman NW; Division of Gynecologic Oncology, Center for Women's Health, Cancer Institute, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA., Conrads TP; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Women's Health Integrated Research Center, Inova Women's Service Line, Inova Health System, Falls Church, VA, USA., Maxwell GL; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Women's Health Integrated Research Center, Inova Women's Service Line, Inova Health System, Falls Church, VA, USA. Electronic address: George.Maxwell@inova.org., Darcy KM; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA; The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA. Electronic address: darcyk@whirc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Apr; Vol. 183, pp. 103-114. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: White People*/statistics & numerical data , Carcinoma, Endometrioid*/genetics , Carcinoma, Endometrioid*/therapy , Carcinoma, Endometrioid*/pathology , Carcinoma, Endometrioid*/ethnology , Carcinoma, Endometrioid*/mortality , Endometrial Neoplasms*/genetics , Endometrial Neoplasms*/therapy , Endometrial Neoplasms*/ethnology , Endometrial Neoplasms*/mortality , Endometrial Neoplasms*/pathology , Black or African American*/statistics & numerical data , Disease Progression*, Humans ; Female ; Middle Aged ; Aged ; Randomized Controlled Trials as Topic ; United States/epidemiology ; SEER Program ; Registries ; Clinical Trials, Phase III as Topic ; Adult